JORGE E CORTES to Multiple Myeloma
This is a "connection" page, showing publications JORGE E CORTES has written about Multiple Myeloma.
Connection Strength
1.118
-
Are Pivotal Clinical Trials for Drugs Approved for Leukemias and Multiple Myeloma Representative of the Population at Risk? J Clin Oncol. 2022 11 10; 40(32):3719-3729.
Score: 0.365
-
Social needs and health-related quality of life among hematologic cancer survivors. Support Care Cancer. 2022 Nov; 30(11):8919-8925.
Score: 0.364
-
Clinical Lymphoma & Myeloma . . . and leukemia too! Clin Lymphoma Myeloma. 2009 Oct; 9(5):344.
Score: 0.150
-
Expanding our mission: Clinical Lymphoma, Myeloma & Leukemia. Clin Lymphoma Myeloma. 2009 Aug; 9(4):266.
Score: 0.148
-
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies. Blood. 2003 Mar 01; 101(5):1692-7.
Score: 0.093